Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine

Clin Infect Dis. 2023 Apr 3;76(7):1205-1208. doi: 10.1093/cid/ciad036.

Authors

Leah Harvey¹, Simeon D Kimmel¹, E Jennifer Edelman²

Affiliations

¹ Sections of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA.
² Department of Internal Medicine and Program in Addiction Medicine, Yale School of Medicine and Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut, USA.

PMID: 36695340
DOI: 10.1093/cid/ciad036

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Buprenorphine* / therapeutic use
Communicable Diseases* / drug therapy
Humans
Opiate Substitution Treatment
Physicians*
Prevalence
United States

Substances

Buprenorphine

Grants and funding